National Centre for Pharmacoeconomics

National Centre for

NCPE Ireland

Lidocaine 5% plasters (Versatis®)

Symptomatic relief of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia, PHN).

Rapid Review

Commenced Completed Outcome
09/09/2010 22/10/2010 Full Pharmacoeconomic Evaluation Recommended.

Pharmacoeconomic Evaluation

Commenced Completed Outcome
10/06/2015 24/09/2015 Reimbursement Not Recommended

The NCPE concludes that the cost effectiveness of the 5% lidocaine plaster has not been demonstrated.